Skyramp | $10,000,000 | (Jun 25, 2025)
Claira(US) | $7,000,000 | (Jun 25, 2025)
Eventual | $20,000,000 | (Jun 25, 2025)
Certified by Founder
Lodge
Therini Bio, Inc.
start up
United States
- South San Francisco, CA
- 27/04/2023
- Series A
- $36,000,000
Therini Bio, Inc. is a biotechnology company dedicated to the research and development of novel therapeutics for the treatment of neuroinflammatory diseases due to vascular dysfunction. Our approach will be generally applicable across a range of inflammatory diseases including peripheral indications. The current therapeutic target is based on novel findings by the Akassoglou lab at Gladstone/UCSF that implicate fibrin as a key driver of neuroinflammation.
- Industry Biotechnology Research
- Website https://www.therinibio.com/
- LinkedIn https://www.linkedin.com/company/therinibio/
CubeNexus Inc | $650,000 | (Jun 25, 2025)
Digital Asset | $135,000,000 | (Jun 25, 2025)
Quinn | $11,000,000 | (Jun 25, 2025)
Waltz | $50,000,000 | (Jun 25, 2025)
OutSee | $2,452,266 | (Jun 25, 2025)
Jobright.ai | $3,200,000 | (Jun 25, 2025)
Empo Health | $7,000,000 | (Jun 25, 2025)
Blank Metal | $3,000,000 | (Jun 25, 2025)
Chronicle Studios | $11,000,000 | (Jun 25, 2025)
Gemist | $6,000,000 | (Jun 25, 2025)